The trusted source for
healthcare information and
Occasionally, patients request that family members be used as egg donors or gestational surrogates. This issue was addressed in a recently updated position paper from the Ethics Committee of the American Society for Reproductive Medicine (ASRM).1
“The ethical considerations surrounding intrafamilial gamete donation and gestational surrogacy focus on the well-being of those who offer to provide reproductive services, those who receive those services, and the offspring born of any such donation,” says Judith Daar, JD, chair of ASRM’s ethics committee. Daar also is clinical professor of medicine at University of California, Irvine School of Medicine.
The position paper states that:
“Concerns that inure specifically to familial gamete donors and gestational carriers cluster around the principle of autonomy,” says Daar.
It is essential that an individual’s participation as a reproductive collaborator be fully informed, unconditionally voluntary, and not the result of coercion or undue influence by the intended parent or other party.
“Our opinion recognizes the potential and unique risk associated with reproductive family dynamics, and strives to help avoid these risks by setting out clear parameters as to the acceptability of various configurations as well as guidance for promoting informed consent,” says Daar.
The committee also considered the effect of intrafamilial donation and surrogacy on the resulting child. Several ethical concerns are highlighted.
“First, as in any donor-conceived or surrogacy scenario, the issue
of disclosure arises,” says Daar.
Family collaborations can involve heightened concerns about disclosure for the donor or surrogate, for that individual’s own offspring, or because of the impression of incest or consanguinity that can arise. Additionally, the offspring’s relationships within the family can be affected as a result of the intrafamilial ART collaboration.
“To address these concerns, the committee recommends that providers take special care to address these and other potential conflicts before proceeding with the requested treatment protocol,” says Daar.
Financial Disclosure: Consulting Editor Arthur R. Derse, MD, JD, Nurse Planner Susan Solverson, BSN, RN, CMSRN, Editor Jill Drachenberg, Editor Dana Spector, AHC Media Editorial Group Manager Terrey L. Hatcher, and Author Stacey Kusterbeck report no consultant, stockholder, speakers’ bureau, research, or other financial relationships with companies having ties to this field of study.